缩写名/全名 |
INTEGR CANCER THER
INTEGRATIVE CANCER THERAPIES |
||||||||||||||||||||
ISSN号 | 1534-7354 | ||||||||||||||||||||
研究方向 | 医学-全科医学与补充医学 | ||||||||||||||||||||
影响因子 | 2015:1.706, 2016:1.923, 2017:2.657, 2018:2.634, 2019:2.379, | ||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||
出版周期 | Quarterly | ||||||||||||||||||||
年文章数 | 103 | ||||||||||||||||||||
出版年份 | 2002 | ||||||||||||||||||||
是否OA | Yes | ||||||||||||||||||||
审稿周期(仅供参考) | >12周,或约稿 |
||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||
投稿链接 | https://us.sagepub.com/en-us/nam/integrative-cancer-therapies/journal201510#submission-guidelines | ||||||||||||||||||||
投稿官网 | https://us.sagepub.com/en-us/nam/integrative-cancer-therapies/journal201510 | ||||||||||||||||||||
h-index | 53 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1534-7354%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Aidi Injection, a Traditional Chinese Medicine Injection, Could Be Used as an Adjuvant Drug to Improve Quality of Life of Cancer Patients Receiving Chemotherapy: A Propensity Score Matching Analysis. Author: Xie G1, Cui Z1, Peng K1, Zhou X1, Xia Q2,3, Xu D1,2,3. Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418810799. doi: 10.1177/1534735418810799. Epub 2018 Nov 27. PubMed DOI |
2. | Shenqi Fuzheng Injection in the Treatment of Breast Cancer: A Meta-analysis of Randomized Controlled Trials. Author: Liu S1, Zhang D1, Wu J1, Wang K1, Zhao Y1, Ni M1, Meng Z1, Zhang X1. Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418816824. doi: 10.1177/1534735418816824. Epub 2018 Dec 4. PubMed DOI |
3. | Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis. Author: Liu Y1, May BH2, Zhang AL2, Guo X1, Lu C1, Xue CC1,2, Zhang H1. Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418817833. doi: 10.1177/1534735418817833. Epub 2018 Dec 10. PubMed DOI |
4. | A Purified Resin Glycoside Fraction from Pharbitidis Semen Induces Paraptosis by Activating Chloride Intracellular Channel-1 in Human Colon Cancer Cells. Author: Zhu D1, Chen C1, Xia Y1, Kong LY1, Luo J1. Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418822120. doi: 10.1177/1534735418822120. Epub 2019 Jan 7. PubMed DOI |
5. | Effects of Shen Cao Granules on Chemotherapy-Induced Thrombocytopenia in Gastrointestinal Cancer Patients: A Randomized Controlled Trial. Author: Yu C1, Liu W1, Mu Y1, Hou A1, Li Y1. Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419829568. doi: 10.1177/1534735419829568. PubMed DOI |
6. | Combination of Astragali Polysaccharide and Curcumin Improves the Morphological Structure of Tumor Vessels and Induces Tumor Vascular Normalization to Inhibit the Growth of Hepatocellular Carcinoma. Author: Tang D1, Zhang S2, Shi X1, Wu J1, Yin G1, Tan X3, Liu F1, Wu X1, Du X1. Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418824408. doi: 10.1177/1534735418824408. PubMed DOI |
7. | Meta-Analysis of 5-Fluorouracil-Based Chemotherapy Combined With Traditional Chinese Medicines for Colorectal Cancer Treatment. Author: Chen P1,2, Ni W2, Xie T1,2, Sui X2. Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419828824. doi: 10.1177/1534735419828824. PubMed DOI |
8. | Network Meta-Analysis of Chinese Herbal Injections Plus the FOLFOX Regimen for the Treatment of Colorectal Cancer in China. Author: Zhang D1, Wu J1, Duan X1, Wang K1, Ni M1, Liu S1, Zhang X1, Zhang B1, Zhao Y1. Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419827098. doi: 10.1177/1534735419827098. PubMed DOI |
9. | The Efficacy of Cognitive Behavioral Therapy to Treat Depression and Anxiety and Improve Quality of Life Among Early-Stage Breast Cancer Patients. Author: Sun H1, Huang H2, Ji S1, Chen X1, Xu Y2, Zhu F3, Wu J1. Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419829573. doi: 10.1177/1534735419829573. PubMed DOI |
10. | Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide, Population-Based Cohort Study. Author: Li CL1, Hsia TC2,3,4,5, Li CH2,3,4, Chen KJ5, Yang YH5,6,7, Yang ST8,9. Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419827079. doi: 10.1177/1534735419827079. PubMed DOI |